Kilitch Drugs (India) Limited (KDIL) is a leading pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations in various dosage forms across the globe.

KDIL has a strong presence in injectables and is one of the largest manufacturers of cephalosporins in Africa, with manufacturing units in India and Ethiopia.

The company's historical growth includes strategic international partnerships and expansions, notably in Yemen and Latin America, to enhance its manufacturing and distribution capabilities.

KDIL's product portfolio includes sterile dosages, nutraceuticals, cosmetics, and medical devices, catering to both chronic and acute treatments.

Despite the sale of its Paonta Sahib unit, KDIL retains core assets and trademarks, continuing to operate from Mumbai with strategic product partnerships and transfers.